Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation
- PMID: 19890024
- DOI: 10.1210/jc.2009-1360
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation
Abstract
Context: Mixed PRL- and GH-secreting pituitary adenomas are relatively common because somatotrophs and lactotrophs share the common somato-mammotroph progenitor lineage. Conversely, the occurrence of a prolactinoma evolving into clinically and biochemically active acromegaly is a rare phenomenon.
Objective and results: We report a patient with a prolactinoma who after 15 yr of disease control by bromocriptine became resistant to dopaminergic drugs and due to the rapid tumor growth was submitted to four neurosurgeries and two stereotactic radiotherapies in the subsequent 5 yr. Unexpectedly, in the last 1.5 yr, after the fourth neurosurgery and second gamma-knife, she complained of signs and symptoms of acromegaly that was biochemically confirmed. Histological examination of the surgical specimens revealed high Ki67 and p53 and low D2 receptor expression. Although samples from the initial surgery were positive for prolactin and negative for GH, about 10% of GH-positive cells were detected in tissue from the last surgery, consistent with the observed clinical shift to acromegaly. Molecular screening failed to find mutations in RAS, TP53, and BRAF hot spots, whereas Arg201His mutation in GNAS gene (gsp oncogene), absent in the previous surgical materials, was detected in the tumor from the last surgery, which was found to be monoclonal.
Conclusions: These observations suggest that 1)treatment of prolactinomas resistant to dopaminergic drugs is still a challenge, and 2) the appearance of gsp oncogene in a prolactinoma evolving into acromegaly might be the underlying mechanism of this rare transition, further confirming that this mutational change is associated with somatotroph growth and transformation.
Similar articles
-
GH/PRL-secreting pituitary macroadenoma associated with GNAS p.Gln227Leu mutation: pediatric case report and review.Endocr J. 2019 May 28;66(5):403-408. doi: 10.1507/endocrj.EJ18-0370. Epub 2019 Mar 28. Endocr J. 2019. PMID: 30814395 Review.
-
GNAS imprinting and pituitary tumors.Mol Cell Endocrinol. 2010 Sep 15;326(1-2):15-8. doi: 10.1016/j.mce.2010.04.009. Epub 2010 Apr 14. Mol Cell Endocrinol. 2010. PMID: 20398730 Review.
-
Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.Pituitary. 2007;10(3):275-82. doi: 10.1007/s11102-007-0058-2. Pituitary. 2007. PMID: 17594522
-
Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment.Int J Cancer. 2007 Sep 15;121(6):1245-52. doi: 10.1002/ijc.22816. Int J Cancer. 2007. PMID: 17514647
-
Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.J Endocrinol. 2001 Feb;168(2):221-6. doi: 10.1677/joe.0.1680221. J Endocrinol. 2001. PMID: 11182759
Cited by
-
Phenotype Transformation of PitNETs.Cancers (Basel). 2024 Apr 29;16(9):1731. doi: 10.3390/cancers16091731. Cancers (Basel). 2024. PMID: 38730682 Free PMC article. Review.
-
Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature.Int J Mol Sci. 2023 Sep 12;24(18):14002. doi: 10.3390/ijms241814002. Int J Mol Sci. 2023. PMID: 37762304 Free PMC article. Review.
-
Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1585-1601. doi: 10.1210/clinem/dgad098. J Clin Endocrinol Metab. 2023. PMID: 36856733 Free PMC article.
-
Metachronous Double Pituitary Adenoma with Altered Transcriptional Factor Profile: A Case Report and Literature Review.NMC Case Rep J. 2021 Oct 7;8(1):657-663. doi: 10.2176/nmccrj.cr.2021-0121. eCollection 2021. NMC Case Rep J. 2021. PMID: 35079531 Free PMC article.
-
Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis.AIMS Neurosci. 2021 Feb 7;8(2):254-283. doi: 10.3934/Neuroscience.2021014. eCollection 2021. AIMS Neurosci. 2021. PMID: 33709028 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous